Commercial League manages a substantial organization of assets and a country-wide infrastructure, which are unique in the industry and distinguish the company from its competitors. Historically, the company is known as the gateway to the market of new pharmaceuticals and medical equipment in the region. The experience gained along with the market research and intelligence throughout multiple partnerships in the field of promotion, health insurance forecasting, marketing, regulatory affairs, distribution and wholesale is one of our greatest intangible assets.
We utilize our resources, codify routines and procedures, embedding capabilities that go beyond general business practices, while simultaneously developing the skills of our talented employees. Commercial League is far ahead in the management of financial risk as compared to our major peers in the region.
Over the years, Commercial League has been recognized for its superior distribution and logistics capacity, IT capabilities as well as brand building expertise. This has an important influence on the quantum of its major contract sales such as state tenders and financial performance. The fact that Commercial League has been so successful in the recent past is a good indication that it would be successful in the future, particularly in the manufacture and market entry of new biotech and personalized medicines.
As the largest company of its type in Bulgaria, Commercial League follows the industry’s mission through strong reform advocacy and public relations campaigns as well as popular public events. Our flexibility and wide reach make us the most advanced and most often chosen strategic partner in confidential market research and intelligence as well as in the field of patent protected drug marketing across Central and Eastern Europe.
Commercial League holds senior and very distinctive competencies and expertise, while outperforming competitors through:
Through its unmatched marketing strategy and know-how, Commercial League has introduced to Bulgarian patients a number of novel treatments for hypertension, diabetes, COPD, CNS disorders, multiple sclerosis, psoriasis, pulmonary hypertension, hyperphosphatemia in patients with end-stage renal failure, rheumatoid arthritis, and many more in mass and unmet orphan diseases.
We have a strong reputation as an innovative and competent company with a notable stance on hot issues in Bulgarian healthcare, which has earned us high recognition from medical professionals and the public. Today Commercial League is the leader in modernity and market dynamics, shaping the future of the sector.
We follow our inherent impetus to seek to obtain and retain a competitive advantage through new products and services, constantly fostering its integration. Our leadership in terms of advocating relief on targeting pharmaceuticals for national cost-containment measures is established. Further support of such continuous leadership provide promotion and sales of new pharmaceuticals and healthcare communication that rests on a forward-looking corporate culture unknown in our geographic area: determined, progressive and performing.
Together with Tchaikapharma, Commercial League empploys more than 140 highly qualified medical representatives throughout Bulgaria who have fostered excellent relations with medical professionals, regulators (the Regional Healthcare Centers with the Ministry of Health) and communities at large.
These relationships with the medical community have been fortified by the events organized by Commercial League such as symposia, conferences, road shows, National Cardiac Days and more. These conferences and gatherings have always enjoyed wide attendance, turning into memorable discussions and remarkable moments shared by many keen healthcare professionals and led by eminent experts and professors of medicine from all over the world.
Commercial League retains a loyal customer base, runs the most sophisticated customer and partner relationship management system in the country, based on customized SAP P/3 platform. We reach more than 3,000 pharmacies, 350 hospitals, university centers and outpatient policlinics.